[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100458210":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":23,"locations":29,"responsibleParty":46,"collaborators":10,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Hospital del Rio Hortega","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"intervention",null,"EUS-guided Entero-biliary Anastomosis",[13],"Procedure: EUS-guided Entero-biliary Anastomosis",[15],{"type":16,"name":11,"description":11,"armGroupLabels":17,"otherNames":10},"PROCEDURE",[9],[19],{"name":20,"affiliation":21,"role":22},"Carlos Maroto Martin, PI","Hospital Rio Hortega","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Carlos Maroto Martín, PI","CONTACT","983420400","cmarotom@saludcastillayleon.es",[30],{"facility":21,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Valladolid","47012","Spain","ES",{"type":37,"coordinates":38},"Point",[39,40],-4.72353,41.65541,{"lat":40,"lon":39},[43],{"name":44,"role":26,"phone":27,"phoneExt":10,"email":45},"Marina De Benito, MD","mbenitosa@saludcastillayleon.es",{"type":22,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Marina de Benito Sanz","Principal Investigator","100458210",false,"NCT05246657","EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions","EUS-guided Entero-biliary Anastomosis as Fistulas for Therapeutic Access in Benign Biliary Obstructions Not Accessible by ERCP","ATENHEA","Inclusion Criteria:\n\n* • Consecutive patients ≥ 18 years old.\n\n  * Benign biliary obstruction.\n  * ERCP failed or where ERCP could not be performed due to surgically-altered anatomy\n\nExclusion Criteria:\n\n* • Refusal to sign the informed consent.\n\n  * Malignant biliary obstruction\n  * Coagulopathy (INR\\>1.5) or trombocytopenia (\\\u003C50,000 platelets\u002Fmm3) uncorrectable.\n  * Inability to tolerate the sedation necessary for the examination.\n  * Pregnancy or lactation.\n  * Unable to follow-up","ALL","18 Years",{"count":59,"type":60},50,"ESTIMATED","OBSERVATIONAL","Background: Transpapillary EUS-BD (rendezvous\u002Fantegrade) is gaining acceptance in BBO. The potential of transmural EUS-BD (hepaticogastrostomy\u002Fcholedochoduodenostomy) in complex BBO warrants study.\n\nAims: To assess feasibility and efficacy of TEA using transmural covered self-expandable metal-stents (cSEMS) to provide interval biliary drainage and create TAF for biliary endotherapy under cholangioscopy or fluoroscopy in BBO not amenable to ERCP.",[64],"Cholangiopancreatography, Endoscopic Retrograde","2025-03-10",{"date":67,"type":68},"2025-03-11","ACTUAL",{"date":70,"type":68},"2021-06-01",{"date":72,"type":60},"2026-07-01",{"name":5,"class":6},1]